Delcath Systems Inc (DCTH)

[Rapture2020]

Love it.

I don’t really talk much about her. I know that when I first bought in, she was the most despised human being on the planet. Given the PPS over the past few years, I understand the frustration.

I jumped in beginning Oct 2017 and all I’ve seen is a no nonsense CEO who laid it out as plain as day: RS or BK.

Then came earnings. BOOM. Then came BOD Phase 3 commercialization whiz bang. BOOM. Then came interim safety analysis report. BOOM. Then came peer-reviewed article in a well respected oncology magazine. BOOM. Then came FDA agreeing to lift certain requirements to get more folks to sign up. BOOM.

Barring a catastrophic failure which would somehow invalidate over 450 CHEMSAT treatments in Europe (there isn’t one), it’s not if, but when FDA approval is given.

In my opinion, she is where CEO Hobbs was in late 2012/early 2013. Only this time, she’s got an Ace up her sleeve—and she knows it.